)
Burning Rock Biotech (BNR) investor relations material
Burning Rock Biotech Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved positive operating cash flow in 3Q25, reversing prior negative trends and marking a significant milestone toward profitability.
Total revenues for 3Q25 were RMB 131.6 million (US$18.5 million), up 2.3% year-over-year, driven by strong pharma R&D services growth.
Net loss narrowed to RMB16.8 million (US$2.4 million) from RMB35.7 million in Q3 2024.
Gross profit margin improved to 75.1% in 3Q25, up 3.7 percentage points year-over-year, driven by product mix optimization and cost control.
Presented significant clinical study results in therapy selection and early cancer detection, and received regulatory approval in Japan for a companion diagnostic system.
Financial highlights
Pharma R&D services revenue surged 68.6% year-over-year to RMB42.0 million, offsetting declines in in-hospital and central laboratory channels.
Gross profit for 3Q25 was RMB 98.8 million, up 8% year-over-year; gross profit margin reached 75.1%.
Adjusted EBITDA loss narrowed to RMB (5.4) million in 3Q25 from RMB (16.6) million in 3Q24, showing a clear trend toward breakeven.
Operating expenses were reduced by 13% year-over-year in 3Q25, with disciplined cuts across R&D, S&M, and G&A.
Cash, cash equivalents, and restricted cash stood at RMB467.0 million (US$65.6 million) as of September 30, 2025.
Outlook and guidance
Continued focus on driving profitability through efficiency gains, cost control, and revenue growth in overseas and biopharma segments.
Expectation of further cost savings and improved sales efficiency going forward.
Management highlighted ongoing transition to in-hospital testing and continued focus on high-margin pharma R&D projects.
Forward-looking statements caution about risks and uncertainties due to market and operating conditions.
Next Burning Rock Biotech earnings date
Next Burning Rock Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage